{
    "additionDate": "2020-01-14T20:04:57Z",
    "bioagentsCURIE": "bioagents:PAVFinder",
    "bioagentsID": "PAVFinder",
    "confidence_flag": "agent",
    "description": "Fusion detection in assembled transcriptomes.\n\nPost-Assembly Variant Finder (PAVFinder).\n\nPAVFinder is a Python package that detects structural variants from de novo assemblies (e.g. ABySS, Trans-ABySS). As such, it is able to analyse both genome and transcriptome assemblies:.",
    "editPermission": {
        "type": "public"
    },
    "function": [
        {
            "operation": [
                {
                    "term": "De-novo assembly",
                    "uri": "http://edamontology.org/operation_0524"
                },
                {
                    "term": "Transcriptome assembly",
                    "uri": "http://edamontology.org/operation_3258"
                },
                {
                    "term": "Variant calling",
                    "uri": "http://edamontology.org/operation_3227"
                }
            ]
        }
    ],
    "homepage": "https://github.com/bcgsc/pavfinder",
    "language": [
        "Python"
    ],
    "lastUpdate": "2021-01-05T09:50:30Z",
    "name": "PAVFinder",
    "owner": "Pub2Agents",
    "publication": [
        {
            "doi": "10.1093/BIOINFORMATICS/BTZ902",
            "metadata": {
                "abstract": "Â© 2019 The Author(s). Published by Oxford University Press.Summary: Presence or absence of gene fusions is one of the most important diagnostic markers in many cancer types. Consequently, fusion detection methods using various genomics data types, such as RNA sequencing (RNA-seq) are valuable agents for research and clinical applications. While information-rich RNA-seq data have proven to be instrumental in discovery of a number of hallmark fusion events, bioinformatics agents to detect fusions still have room for improvement. Here, we present Fusion-Bloom, a fusion detection method that leverages recent developments in de novo transcriptome assembly and assembly-based structural variant calling technologies (RNA-Bloom and PAVFinder, respectively). We benchmarked Fusion-Bloom against the performance of five other state-of-the-art fusion detection agents using multiple datasets. Overall, we observed Fusion-Bloom to display a good balance between detection sensitivity and specificity. We expect the agent to find applications in translational research and clinical genomics pipelines.",
                "authors": [
                    {
                        "name": "Birol I."
                    },
                    {
                        "name": "Chiu R."
                    },
                    {
                        "name": "Nip K.M."
                    }
                ],
                "citationCount": 1,
                "date": "2020-04-01T00:00:00Z",
                "journal": "Bioinformatics",
                "title": "Fusion-Bloom: Fusion detection in assembled transcriptomes"
            },
            "pmid": "31790154"
        }
    ],
    "agentType": [
        "Command-line agent"
    ],
    "topic": [
        {
            "term": "Biomarkers",
            "uri": "http://edamontology.org/topic_3360"
        },
        {
            "term": "Gene transcripts",
            "uri": "http://edamontology.org/topic_3512"
        },
        {
            "term": "RNA-Seq",
            "uri": "http://edamontology.org/topic_3170"
        },
        {
            "term": "Sequence assembly",
            "uri": "http://edamontology.org/topic_0196"
        },
        {
            "term": "Transcriptomics",
            "uri": "http://edamontology.org/topic_3308"
        }
    ],
    "validated": 1
}
